E-cigarette or Vaping product use Associated Lung Injury (EVALI) in the time of COVID-19: A clinical dilemma
Daniel Helfgott MD*, Gabrielle Capozzoli MD*, Jovanna Madray DO*, Aisha Baig MD#, Lakshmi Uppaluri MD#,Sunanda Gaur MD+, Mitchell Simon^, Judith Amorosa^, Maya Ramagopal, MD#
*Department of Pediatrics, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ
# Division of Pulmonology and Cystic Fibrosis Center, Department of Pediatrics, Rutgers-Robert Wood Johnson Medical School New Brunswick, NJ
+Department of Infectious Diseases, Allergy and Immunology, Department of Pediatrics, Rutgers-Robert Wood Johnson Medical School New Brunswick, NJ
New Brunswick, NJ
Key words: EVALI, COVID-19,clinical features, laboratory findings